Bard PowerPort Broke Inside You in 2026? The Fracture, the Revision Surgery, and Your Claim

If your implanted Bard PowerPort catheter has fractured or moved from where it was placed, you may have a product claim: federal cases are coordinated in MDL No. 3081, and a 2026 jury awarded $40 million in one fracture case. This guide explains the failure, the records that prove it, and your next steps.

  • Federal Bard implanted-port cases were centralized on August 8, 2023, as MDL No. 3081 in the U.S. District Court for the District of Arizona, before Judge David G. Campbell.
  • The Judicial Panel on Multidistrict Litigation reported 4,140 actions pending in MDL No. 3081 as of October 1, 2026.
  • On September 4, 2026, a federal jury awarded $40 million in compensatory damages in Divelbliss v. C.R. Bard, where the catheter fractured and a fragment migrated to the right atrium of the heart.
  • Plaintiffs allege the catheter contains too high a concentration of barium sulfate, which they claim weakens it; defendants dispute this, and no court has decided liability on an MDL-wide basis.
  • Compensation varies widely by case, and most settlements are confidential.

For plain-language walkthroughs of everyday consumer and money problems, see the Problem Solved channel. The rest of this guide stays with the device: what breaks, what it does inside the body, and what turns a frightening medical event into a claim that can be proved.

What Actually Breaks Inside a PowerPort

A port has two parts: the small reservoir under the skin and the catheter, the flexible tube carrying medicine into a large vein. In the cases now before the courts, the alleged failure is in the catheter. Plaintiffs allege it contains too high a concentration of barium sulfate, added so the tube shows up on imaging, and that this weakens it over time. Defendants dispute that theory. Patients report a consistent pattern: a catheter that cracks, splits, or breaks apart, sometimes years after implantation.

The Fracture, the Migration, and the Revision Surgery

Migration is the word for a device, or a piece of one, moving from its original site. A fractured fragment can travel with the bloodstream toward the heart or lungs, where it can block blood flow, tear tissue, or force an emergency retrieval. Even a partial crack can leak medicine into surrounding tissue or let bacteria in, causing infection, clots, or sepsis. Revision surgery is the operation that fixes or replaces the failed device: removing the port, replacing the catheter, or retrieving a fragment, sometimes with a new access device elsewhere. Keep every record of that operation, including what was found and what happened to the removed device, because the device itself is evidence.

Where the Cases Stand: MDL No. 3081

Multidistrict litigation, shortened to MDL, gathers similar federal lawsuits before one judge for shared pretrial work: the same documents, expert witnesses, and evidence rulings. On August 8, 2023, the Judicial Panel on Multidistrict Litigation centralized the federal Bard implanted-port cases as MDL No. 3081, In re: Bard Implanted Port Catheter Products Liability Litigation, in the District of Arizona under Judge David G. Campbell, with 4,140 actions pending as of October 1, 2026. Bellwether trials are test trials of representative cases, tried first so both sides can see how juries weigh the evidence; the program runs through early 2027. No MDL-wide finding of liability has been made.

The Records That Prove a Fracture Claim

A claim like this is proved with paper, not adjectives. The file that matters has five parts: the implant record with device model, lot number, and date; imaging with the radiologist's report showing the break or the fragment's location; the operative and retrieval reports describing what was removed and its condition; the treatment record for infection, clotting, or cardiac care that followed; and the bills and work record showing what the extra procedures cost. Request your complete records rather than a summary, and if a hospital says the removed device was discarded, get that answer in writing with a date and a name. The same preservation lesson, from a different device, is explained here: The Hospital Discarded Your Explanted Hernia Mesh? 5 Records That Keep Your Product Claim Alive in 2026.

Who Benefits From This — and Who Does Not

Patients who benefit most are those whose catheter fractured or migrated and who needed retrieval surgery, replacement surgery, or treatment for infection, clotting, or sepsis that their doctors link to the device. Their cases rest on a visible event, a procedure, and a record connecting the two. Families benefit too when a cardiac injury followed a documented fragment migration.

Three groups should pause before filing. The first is patients whose port is intact and working, with no fracture, infection, or migration; for them the useful guide is the warning-signs article for a port still in the chest: No Fracture, No Infection — Just a Bard PowerPort Still in Your Chest in 2026? The 5 Warning Signs, the Removal Question, and the Records That Protect a Future Claim. The second is patients whose complication came from their underlying illness or a different device. The third is anyone expecting one MDL payout for all patients: these are individual claims, each proved on its own facts. A related lesson from another implanted device that broke apart inside patients is here: Your Acid Reflux Implant Broke Apart Inside You: the LINX Recall, the Removal Surgery, and the November 2028 Trial Date.

Your Next Steps, in Order

Start with medicine, not law. Chest pain, shortness of breath, swelling, fever, or a port that suddenly will not flush all warrant emergency care; tell the team you have an implanted port and suspect a catheter problem. Then, in order: request your implant and imaging records; put the device-preservation request in writing; build the dated timeline; and take the file to a product-liability attorney for a deadline check, because limitation periods differ by state and some run from discovery of the problem, not implantation. Two mistakes to avoid: waiting for the MDL to finish, which does not pause your personal deadline, and signing a broad medical release or accepting a device replacement in exchange for a release before getting advice.

General Information, Not Legal Advice

This article is general information about a pending litigation and is not legal or medical advice. Litigation facts change as new orders and verdicts arrive, and deadlines and rules differ by state. Speak to a licensed attorney in your jurisdiction about your own situation, and to your treating doctor about any symptom or device concern.

Frequently Asked Questions

What is a Bard PowerPort, in plain terms?

A Bard PowerPort is an implanted port placed under the skin, usually in the chest, that gives doctors repeated access to a vein for chemotherapy and other medicines. A thin tube, called a catheter, runs from the port into a large vein.

Who benefits from pursuing a Bard PowerPort claim?

Patients whose catheter fractured, migrated, or leaked and who needed retrieval surgery, replacement surgery, or treatment for infection, clotting, or sepsis linked to the device benefit most. Families also benefit when a cardiac injury followed a documented fragment migration, because imaging can connect the device to the harm.

Who does not benefit, or for whom is this claim not the right move?

This claim is not the right move if your port is intact, working, and has never broken or become infected; monitoring matters more there than a claim. It is also a weak fit if the problem came from an unrelated illness or a different device, because a claim must connect this catheter to the injury with medical evidence.

How do I start a Bard PowerPort claim?

First, get your implant record, operative report, and imaging showing the fracture or migration. Second, ask in writing that any removed device or fragment be preserved, not discarded. Third, write a dated timeline of symptoms, emergency visits, and procedures. Fourth, take that file to a product-liability attorney promptly, because filing deadlines differ by state and claim type.

Is the Bard PowerPort litigation a class action?

No. It is a multidistrict litigation, a procedure that coordinates individual federal cases for shared pretrial work such as evidence and expert testimony. Each person keeps an individual claim and must prove their own injury and causation; one verdict does not decide every case.

What did the $40 million Divelbliss verdict actually decide?

It decided one plaintiff's case: the jury found for Kimberly Divelbliss after her catheter fractured and a fragment migrated to the right atrium of her heart. It was the second bellwether trial completed in the MDL and the first fracture case to reach a verdict, but it does not set the value of any other case.

Watch on YouTube

Problem Solved on YouTube